DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

Allergan, Inc. (NYSE: AGN)

166.12 -2.09 (-1.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AGN $166.12 -1.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $167.23
Previous Close $168.21
Daily Range $164.93 - $168.11
52-Week Range $88.34 - $174.49
Market Cap $49.4B
P/E Ratio 38.58
Dividend (Yield) $0.20 (0.1%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/05/14
Volume 1,133,357
Average Daily Volume 1,741,738
Current FY EPS $5.79

Sector

Healthcare

Industry

Drugs

Allergan, Inc. (AGN) Description

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc. Website: http://www.allergan.com/

News & Commentary Rss Feed

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog

Botox maker Allergan rejected Actavis takeover bid

Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog

Allergan And Valeant: Lessons From The Go-Go Years

Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog

Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog

Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog

See More AGN News...

AGN's Top Competitors

AGN $166.12 (-1.24%)
Current stock: AGN
JNJ $107.88 (-0.10%)
Current stock: JNJ
NVS $94.06 (0.17%)
Current stock: NVS
RHHBY $37.66 (0.07%)
Current stock: RHHBY